LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study

ABSTRACT:

SUBMITTER: Bersanelli M 

PROVIDER: S-EPMC7506488 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature